{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"groups":[{"description":"KRT-232 60 mg + KRd","id":"OG000","title":"Part A: Dose Level 1"},{"description":"KRT-232 90 mg + KRd","id":"OG001","title":"Part A: Dose Level 2"}],"populationDescription":"Data were not collected due to study termination prior to participants' assessment at the pre-specified time points.","reportingStatus":"POSTED","timeFrame":"30 days after last dose","title":"Evaluate PD Effects of KRT-232 (AMG 232) Through Serum MIC-1 Levels.","type":"SECONDARY"}